期刊文献+

食管癌的靶向药物治疗现状 被引量:2

Current status of targeted therapy for esophageal cancer
原文传递
导出
摘要 食管癌是临床常见的恶性肿瘤,手术及放化疗治疗效果较差。食管癌的靶向药物治疗是近年临床以及药物研发的关注焦点,本文简要综述食管癌的靶向药物治疗评价。 Esophageal cancer is clinical common malignant tumor. The effects of surgery and chemo/radiation in esophageal cancer are still poor. In recent years, esophageal cancer targeted therapy has become a hot concern. This paper provides a brief review on current esophageal cancer targeted therapy.
出处 《世界临床药物》 CAS 2015年第6期378-383,共6页 World Clinical Drug
关键词 食管癌 靶向治疗 药物评价 esophageal cancer targeted therapy drug evaluation
  • 相关文献

参考文献20

  • 1Ning-Yi Ma,Xu-Wei Cai,Xiao-Long Fu,Yuan Li,Xiao-Yan Zhou,Xiang-Hua Wu,Xi-Chun Hu,Min Fan,Jia-Qing Xiang,Ya-Wei Zhang,Hai-Quan Chen,Song-Tao Lai,Guo-Liang Jiang,Kuai-Le Zhao.Safety and efficacy of nimotuzumab in combination with radiotherapy for patients with squamous cell carcinoma of the esophagus[J]. International Journal of Clinical Oncology . 2014 (2)
  • 2Tanja Trarbach,Marta Przyborek,Norbert Schleucher,Steffen Heeger,Christian Lüpfert,Udo Vanhoefer.Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas[J].Investigational New Drugs.2013(3)
  • 3Tom Waddell,Ian Chau,David Cunningham,David Gonzalez,Alicia Frances,Clare Okines,Andrew Wotherspoon,Claire Saffery,Gary Middleton,Jonathan Wadsley,David Ferry,Wasat Mansoor,Tom Crosby,Fareeda Coxon,David Smith,Justin Waters,Timothy Iveson,Stephen Falk,Sarah Slater,Clare Peckitt,Yolanda Barbachano.Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 4Yongshun Chen,Xiaoyuan Wu,Shanshan Bu,Chunyu He,Wen Wang,Jinsong Liu,Wei Guo,Bo Tan,Yanxia Wang,Jianhua Wang.Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma[J]. Cancer Sci . 2012 (11)
  • 5David Adelstein,Cristina Rodriguez,Lisa Rybicki,Denise Ives,Thomas Rice.A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction[J]. Investigational New Drugs . 2012 (4)
  • 6Kuai-le Zhao,Xi-chun Hu,Xiang-hua Wu,Xiao-long Fu,Min Fan,Guo-Liang Jiang.A phase I dose escalation study of Nimotuzumab in combination with concurrent chemoradiation for patients with locally advanced squamous cell carcinoma of esophagus[J]. Investigational New Drugs . 2012 (4)
  • 7Jordan M. Schmitt,Scott R. Sommers,William Fisher,Rafat Ansari,Erwin Robin,Karuna Koneru,John McClean,Ziyue Liu,Yan Tong,Nasser Hanna.Sunitinib Plus Paclitaxel in Patients with Advanced Esophageal Cancer: A Phase II Study from the Hoosier Oncology Groupe[J]. Journal of Thoracic Oncology . 2012 (4)
  • 8Philip J. Gold,Bryan Goldman,Syma Iqbal,Lawrence P. Leichman,Wu Zhang,Heinz-Josef Lenz,Charles D. Blanke.Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)[J]. Journal of Thoracic Oncology . 2010 (9)
  • 9Yung-Jue Bang,Eric Van Cutsem,Andrea Feyereislova,Hyun C Chung,Lin Shen,Akira Sawaki,Florian Lordick,Atsushi Ohtsu,Yasushi Omuro,Taroh Satoh,Giuseppe Aprile,Evgeny Kulikov,Julie Hill,Michaela Lehle,Josef Rüschoff,Yoon-Koo Kang.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial[J]. The Lancet . 2010 (9742)
  • 10Ian Smith,Marion Procter,Richard D Gelber,Sébastien Guillaume,Andrea Feyereislova,Mitch Dowsett,Aron Goldhirsch,Michael Untch,Gabriella Mariani,Jose Baselga,Manfred Kaufmann,David Cameron,Richard Bell,Jonas Bergh,Robert Coleman,Andrew Wardley,Nadia Harbeck,Roberto I Lopez,Peter Mallmann,Karen Gelmon,Nicholas Wilcken,Erik Wist,Pedro Sánchez Rovira,Martine J Piccart-Gebhart.2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial[J]. The Lancet . 2007 (9555)

共引文献13

同被引文献21

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部